🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Formulation 4

Found 0 matching trials

Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy

PHASE3

This clinical study is a randomized, double-blind, double-dummy, parallel g...

Status

Suspended

Location

Sun City Clinical Research

Start Date

2022-12-14

Trial ID

NCT05324358

Treatments Being Tested

Ketorolac Tromethamine Morphine Sulfate Intravenous Placebo for NTM-001 IV Placebo for Morphine

An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations

PHASE1

This is a double-blinded, randomized, pharmacokinetic and safety study of 3...

Status

Completed

Location

Johns Hopkins University, Division of Clinical Pharmacology, Drug Development Unit

Start Date

2013-03

Trial ID

NCT01575418

Treatments Being Tested

Rectal formulation (RF) of tenofovir 1% gel Vaginal formulation (VF) of tenofovir 1% gel Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel Radiolabeling of study drugs and semen

A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects

PHASE1

The primary objective of this pilot study is to determine the within-subjec...

Status

Completed

Location

PPD Phase 1 Unit

Start Date

2011-10

Trial ID

NCT01452542

Treatments Being Tested

Eliglustat, common blend proposed commercial formulation Eliglustat, Phase 3 capsule formulation

A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration

PHASE3

This multicenter study in participants with HER2-positive eBC will investig...

Status

Completed

Location

State Inst N.N. Alexandrov Republican Scientific & Practical Centre of Oncology & Medical Radiology

Start Date

2014-07-18

Trial ID

NCT02194166

Treatments Being Tested

Trastuzumab Paclitaxel Docetaxel

A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease

PHASE1

This study is an open-label of single transdermal dose of DSP-9632P to eval...

Status

Completed

Location

Nippon Medical School Hospital

Start Date

2022-05-31

Trial ID

NCT05435729

Treatments Being Tested

DSP-9632P 27.5 mg DSP-9632P 82.5 mg Placebo DSP-9632P 55.0 mg Levodopa formulation

Monitoring Postprandial Blood Glucose and Insulin in Fruit Snacks

The goal of this clinical trial is to compare the postprandial glucose and ...

Status

Completed

Location

Biofortis Innovation Services

Start Date

2024-05-22

Trial ID

NCT06458946

Treatments Being Tested

Fruit snack 1 Fruit snack 2 Fruit snack 3 Fruit snack 4 Fruit snack 5 Confection control

To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults

PHASE1

The purpose of this study is to learn about the study medicine CTB-AVP for ...

Status

Completed

Location

Pfizer Clinical Research Unit - Brussels

Start Date

2024-07-29

Trial ID

NCT06593054

Treatments Being Tested

Ceftibuten Avibactam prodrug CTB-AVP in Tablet

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

PHASE1

Evaluate the safety and tolerability of sotorasib in adult subjects with KR...

Status

Completed

Location

City of Hope National Medical Center

Start Date

2018-08-27

Trial ID

NCT03600883

Treatments Being Tested

sotorasib Anti PD-1/L1 Midazolam

The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis

PHASE1

The objectives of this clinical trial were to determine the radioprotective...

Status

Completed

Location

Zhejiang Cancer Hospital

Start Date

2023-03-22

Trial ID

NCT06861179

Treatments Being Tested

The formulation of Compound Phellinus igniarius decoction

Phase I BP Interferon (IFN) Beta-004

PHASE1

Phase I study aiming at: * establishing the pharmacokinetic profile of int...

Status

Completed

Location

Multiple Locations

Start Date

2006-05

Trial ID

NCT02517788

Treatments Being Tested

Interferon beta-1a HSA-free biosimilar Interferon beta-1a HSA+ biosimilar Interferon beta-1a original

Previous Next